50462
A&P Inphatec Announces 2020 Field Trial Efficacy Results for XylPhi-PD™
Palo Alto, CA – April 27, 2021– A&P Inphatec, a specialist developer of bacteriophages, announced today the release of important new field trial data on the efficacy of XylPhi-PD™, the biologically...